Best Practices

The glycoprotein IIb/IIIa inhibitor tirofiban (Aggrastat) is “non-inferior” to its more expensive counterpart abciximab (ReoPro) in ST-elevation MI patients undergoing percutaneous coronary intervention.

Under-50s who have had ‘silent’ strokes are at higher risk for another stroke; MRIs recommended for all young stroke patients

Canadian researchers have suggested previously that prevention of catheter thrombosis sometimes seen with the anticoagulant fondaparinux can be attenuated using standard doses of unfractionated heparin.

Is having an intrauterine device more likely to increase a woman’s chance of having bacterial vaginosis?

When it comes to making positive changes in lifestyle and medication adherence among patients following an acute coronary syndrome, nurses trump “usual care” performed by physicians.

Attempting procedure at 33 to 34 weeks doesn’t reduce C-section rate